Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Biological Unit 1
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)

(-) Description

Title :  COMPLEMENT RECEPTOR TYPE 2
 
Authors :  H. E. Gilbert, R. Asokan, V. M. Holers, S. J. Perkins
Date :  27 Apr 06  (Deposition) - 26 Sep 06  (Release) - 07 Apr 10  (Revision)
Method :  SOLUTION SCATTERING
Resolution :  NOT APPLICABLE
Chains :  Asym. Unit :  A  (3x)
Biol. Unit 1:  A  (1x)
Keywords :  Complement, Scr Domain, Ccp Domain, Sushi Domain, Immune System (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  H. E. Gilbert, R. Asokan, V. M. Holers, S. J. Perkins
The 15 Scr Flexible Extracellular Domains Of Human Complement Receptor Type 2 Can Mediate Multiple Ligand And Antigen Interactions.
J. Mol. Biol. V. 362 1132 2006
PubMed-ID: 16950392  |  Reference-DOI: 10.1016/J.JMB.2006.08.012

(-) Compounds

Molecule 1 - COMPLEMENT RECEPTOR TYPE 2
    ChainsA
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System CommonFALL ARMYWORM
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    GeneCR2, C3DR
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymCR2, COMPLEMENT C3D RECEPTOR, EPSTEIN-BARR VIRUS RECEPTOR, EBV RECEPTOR, CD21 ANTIGEN

 Structural Features

(-) Chains, Units

  1
Asymmetric Unit (3x)A
Biological Unit 1 (1x)A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (0, 0)

(no "Ligand,Modified Residues,Ions" information available for 2GSX)

(-) Sites  (0, 0)

(no "Site" information available for 2GSX)

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2GSX)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2GSX)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 1)

Asymmetric Unit (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_016164S639NCR2_HUMANPolymorphism17615AS619N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (1, 1)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_016164S639NCR2_HUMANPolymorphism17615AS619N

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 15)

Asymmetric Unit (1, 15)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1SUSHIPS50923 Sushi/CCP/SCR domain profile.CR2_HUMAN21-84
89-148
152-212
213-273
274-344
408-468
349-407
469-524
525-595
600-659
660-716
717-781
786-845
849-909
910-970
  15A:1-64
A:69-128
A:132-192
A:193-253
A:254-324
A:388-448
A:329-387
A:449-504
A:505-575
A:580-639
A:640-696
A:697-761
A:766-825
A:829-889
A:890-950
Biological Unit 1 (1, 15)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1SUSHIPS50923 Sushi/CCP/SCR domain profile.CR2_HUMAN21-84
89-148
152-212
213-273
274-344
408-468
349-407
469-524
525-595
600-659
660-716
717-781
786-845
849-909
910-970
  15A:1-64
A:69-128
A:132-192
A:193-253
A:254-324
A:388-448
A:329-387
A:449-504
A:505-575
A:580-639
A:640-696
A:697-761
A:766-825
A:829-889
A:890-950

(-) Exons   (15, 15)

Asymmetric Unit (15, 15)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003670581aENSE00001952555chr1:207627575-207627821247CR2_HUMAN1-20200--
1.3bENST000003670583bENSE00001069650chr1:207639871-207640257387CR2_HUMAN20-1491301A:1-129129
1.4bENST000003670584bENSE00000882434chr1:207641872-207642060189CR2_HUMAN149-212641A:129-19264
1.5ENST000003670585ENSE00000882436chr1:207642145-207642244100CR2_HUMAN212-245341A:192-22534
1.6ENST000003670586ENSE00000791926chr1:207642495-20764257783CR2_HUMAN245-273291A:225-25329
1.7bENST000003670587bENSE00000882439chr1:207643040-207643447408CR2_HUMAN273-4091371A:253-389137
1.8ENST000003670588ENSE00000882440chr1:207644085-207644261177CR2_HUMAN409-468601A:389-44860
1.9aENST000003670589aENSE00000882441chr1:207644342-20764443291CR2_HUMAN468-498311A:448-47831
1.10ENST0000036705810ENSE00001167936chr1:207644768-20764484477CR2_HUMAN498-524271A:478-50427
1.12bENST0000036705812bENSE00001381764chr1:207646117-207646524408CR2_HUMAN524-6601371A:504-640137
1.14ENST0000036705814ENSE00001167916chr1:207647146-20764723085CR2_HUMAN660-688291A:640-66829
1.15ENST0000036705815ENSE00001167908chr1:207647586-20764766883CR2_HUMAN688-716291A:668-69629
1.16aENST0000036705816aENSE00001167899chr1:207648169-207648561393CR2_HUMAN716-8471321A:696-827132
1.17ENST0000036705817ENSE00001167890chr1:207649579-207649764186CR2_HUMAN847-909631A:827-88963
1.18ENST0000036705818ENSE00001167878chr1:207651230-207651415186CR2_HUMAN909-971631A:889-95163
1.19ENST0000036705819ENSE00001167866chr1:207652602-20765262524CR2_HUMAN971-97991A:951-9511
1.20ENST0000036705820ENSE00001167855chr1:207653323-20765339876CR2_HUMAN979-1004260--
1.21bENST0000036705821bENSE00001246608chr1:207658809-207658917109CR2_HUMAN1004-1033300--
1.22bENST0000036705822bENSE00001841611chr1:207662487-207663240754CR2_HUMAN-00--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:951
 aligned with CR2_HUMAN | P20023 from UniProtKB/Swiss-Prot  Length:1033

    Alignment length:951
                                    30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500       510       520       530       540       550       560       570       580       590       600       610       620       630       640       650       660       670       680       690       700       710       720       730       740       750       760       770       780       790       800       810       820       830       840       850       860       870       880       890       900       910       920       930       940       950       960       970 
            CR2_HUMAN    21 ISCGSPPPILNGRISYYSTPIAVGTVIRYSCSGTFRLIGEKSLLCITKDKVDGTWDKPAPKCEYFNKYSSCPEPIVPGGYKIRGSTPYRHGDSVTFACKTNFSMNGNKSVWCQANNMWGPTRLPTCVSVFPLECPALPMIHNGHHTSENVGSIAPGLSVTYSCESGYLLVGEKIINCLSSGKWSAVPPTCEEARCKSLGRFPNGKVKEPPILRVGVTANFFCDEGYRLQGPPSSRCVIAGQGVAWTKMPVCEEIFCPSPPPILNGRHIGNSLANVSYGSIVTYTCDPDPEEGVNFILIGESTLRCTVDSQKTGTWSGPAPRCELSTSAVQCPHPQILRGRMVSGQKDRYTYNDTVIFACMFGFTLKGSKQIRCNAQGTWEPSAPVCEKECQAPPNILNGQKEDRHMVRFDPGTSIKYSCNPGYVLVGEESIQCTSEGVWTPPVPQCKVAACEATGRQLLTKPQHQFVRPDVNSSCGEGYKLSGSVYQECQGTIPWFMEIRLCKEITCPPPPVIYNGAHTGSSLEDFPYGTTVTYTCNPGPERGVEFSLIGESTIRCTSNDQERGTWSGPAPLCKLSLLAVQCSHVHIANGYKISGKEAPYFYNDTVTFKCYSGFTLKGSSQIRCKADNTWDPEIPVCEKETCQHVRQSLQELPAGSRVELVNTSCQDGYQLTGHAYQMCQDAENGIWFKKIPLCKVIHCHPPPVIVNGKHTGMMAENFLYGNEVSYECDQGFYLLGEKKLQCRSDSKGHGSWSGPSPQCLRSPPVTRCPNPEVKHGYKLNKTHSAYSHNDIVYVDCNPGFIMNGSRVIRCHTDNTWVPGVPTCIKKAFIGCPPPPKTPNGNHTGGNIARFSPGMSILYSCDQGYLLVGEALLLCTHEGTWSQPAPHCKEVNCSSPADMDGIQKGLEPRKMYQYGAVVTLECEDGYMLEGSPQSQCQSDHQWNPPLAVCRSR 971
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------N-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE SUSHI  PDB: A:1-64 UniProt: 21-84                               ----SUSHI  PDB: A:69-128 UniProt: 89-148                        ---SUSHI  PDB: A:132-192 UniProt: 152-212                       SUSHI  PDB: A:193-253 UniProt: 213-273                       SUSHI  PDB: A:254-324 UniProt: 274-344                                 ----SUSHI  PDB: A:329-387 UniProt: 349-407                     SUSHI  PDB: A:388-448 UniProt: 408-468                       SUSHI  PDB: A:449-504 UniProt: 469-524                  SUSHI  PDB: A:505-575 UniProt: 525-595                                 ----SUSHI  PDB: A:580-639 UniProt: 600-659                      SUSHI  PDB: A:640-696 UniProt: 660-716                   SUSHI  PDB: A:697-761 UniProt: 717-781                           ----SUSHI  PDB: A:766-825 UniProt: 786-845                      ---SUSHI  PDB: A:829-889 UniProt: 849-909                       SUSHI  PDB: A:890-950 UniProt: 910-970                       - PROSITE
           Transcript 1 (1) Exon 1.3b  PDB: A:1-129 UniProt: 20-149 [INCOMPLETE]                                                                             --------------------------------------------------------------Exon 1.5  PDB: A:192-225          ---------------------------Exon 1.7b  PDB: A:253-389 UniProt: 273-409                                                                                               ----------------------------------------------------------------------------------------Exon 1.10  PDB: A:478-504  ---------------------------------------------------------------------------------------------------------------------------------------Exon 1.14  PDB: A:640-668    ---------------------------Exon 1.16a  PDB: A:696-827 UniProt: 716-847                                                                                         -------------------------------------------------------------Exon 1.18  PDB: A:889-951 UniProt: 909-971                      Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------------------------------------------------------------------------------Exon 1.4b  PDB: A:129-192 UniProt: 149-212                      --------------------------------Exon 1.6  PDB: A:225-253     ---------------------------------------------------------------------------------------------------------------------------------------Exon 1.8  PDB: A:389-448 UniProt: 409-468                   -------------------------------------------------------Exon 1.12b  PDB: A:504-640 UniProt: 524-660                                                                                              ---------------------------Exon 1.15  PDB: A:668-696    ----------------------------------------------------------------------------------------------------------------------------------Exon 1.17  PDB: A:827-889 UniProt: 847-909                     -------------------------------------------------------------1 Transcript 1 (2)
           Transcript 1 (3) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.9a  PDB: A:448-478      ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (3)
                 2gsx A   1 ISCGSPPPILNGRISYYSTPIAVGTVIRYSCSGTFRLIGEKSLLCITKDKVDGTWDKPAPKCEYFNKYSSCPEPIVPGGYKIRGSTPYRHGDSVTFACKTNFSMNGNKSVWCQANNMWGPTRLPTCVSVFPLECPALPMIHNGHHTSENVGSIAPGLSVTYSCESGYLLVGEKIINCLSSGKWSAVPPTCEEARCKSLGRFPNGKVKEPPILRVGVTANFFCDEGYRLQGPPSSRCVIAGQGVAWTKMPVCEEIFCPSPPPILNGRHIGNSLANVSYGSIVTYTCDPDPEEGVNFILIGESTLRCTVDSQKTGTWSGPAPRCELSTSAVQCPHPQILRGRMVSGQKDRYTYNDTVIFACMFGFTLKGSKQIRCNAQGTWEPSAPVCEKECQAPPNILNGQKEDRHMVRFDPGTSIKYSCNPGYVLVGEESIQCTSEGVWTPPVPQCKVAACEATGRQLLTKPQHQFVRPDVNSSCGEGYKLSGSVYQECQGTIPWFMEIRLCKEITCPPPPVIYNGAHTGSSLEDFPYGTTVTYTCNPGPERGVEFSLIGESTIRCTSNDQERGTWSGPAPLCKLSLLAVQCSHVHIANGYKISGKEAPYFYNDTVTFKCYSGFTLKGSSQIRCKADNTWDPEIPVCEKETCQHVRQSLQELPAGSRVELVNTSCQDGYQLTGHAYQMCQDAENGIWFKKIPLCKVIHCHPPPVIVNGKHTGMMAENFLYGNEVSYECDQGFYLLGEKKLQCRSDSKGHGSWSGPSPQCLRSPPVTRCPNPEVKHGYKLNKTHSAYSHNDIVYVDCNPGFIMNGSRVIRCHTDNTWVPGVPTCIKKAFIGCPPPPKTPNGNHTGGNIARFSPGMSILYSCDQGYLLVGEALLLCTHEGTWSQPAPHCKEVNCSSPADMDGIQKGLEPRKMYQYGAVVTLECEDGYMLEGSPQSQCQSDHQWNPPLAVCRSR 951
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500       510       520       530       540       550       560       570       580       590       600       610       620       630       640       650       660       670       680       690       700       710       720       730       740       750       760       770       780       790       800       810       820       830       840       850       860       870       880       890       900       910       920       930       940       950 

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 2GSX)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2GSX)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2GSX)

(-) Gene Ontology  (21, 21)

Asymmetric Unit(hide GO term definitions)
Chain A   (CR2_HUMAN | P20023)
molecular function
    GO:0003677    DNA binding    Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
    GO:0001848    complement binding    Interacting selectively and non-covalently with any component or product of the complement cascade.
    GO:0004875    complement receptor activity    Combining with any component or product of the complement cascade and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
    GO:0004888    transmembrane signaling receptor activity    Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
    GO:0001618    virus receptor activity    Combining with a virus component and mediating entry of the virus into the cell.
biological process
    GO:0030183    B cell differentiation    The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
    GO:0042100    B cell proliferation    The expansion of a B cell population by cell division. Follows B cell activation.
    GO:0006958    complement activation, classical pathway    Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes.
    GO:0002430    complement receptor mediated signaling pathway    A series of molecular signals generated as a consequence of a component of the complement pathway binding to a complement receptor. Such components include both whole complement proteins and fragments of complement proteins generated through the activity of the complement pathway.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0002376    immune system process    Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0046718    viral entry into host cell    The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 2gsx)
 
  Sites
(no "Sites" information available for 2gsx)
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2gsx)
 
Biological Unit
  Complete Structure
    Biological Unit 1  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2gsx
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  CR2_HUMAN | P20023
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  CR2_HUMAN | P20023
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        CR2_HUMAN | P200231ghq 1ly2 1w2r 1w2s 2aty 3oed

(-) Related Entries Specified in the PDB File

1ghq CR2-C3D COMPLEX STRUCTURE
1w2r SOLUTION STRUCTURE OF FREE CR2 SCR 1-2
2aty COMPLEMENT RECEPTOR CHIMAERIC CONJUGATE CR2-IG